SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive ...
News
- bioAffinity Technologies' Noninvasive CyPath® Lung Test to Be Highlighted at American ... - Nasdaq
- Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio ...
... biotechnology company focused on the discovery and development of proprietary cancer. ... San Antonio Breast Cancer Symposium (SABCS), in San Antonio, ...
- 8th Edition of Euro-Global Conference on Food Science and Technology - Austin Monthly Magazine
P.O. Box 2171. San Antonio, TX 78297-2171. 512-275-0172. © 2025 Hearst Newspapers, LLC. All rights reserved. Website by Web Publisher PRO. ×.
- PreciseDxR Presents New Data for PreciseBreastR, an AI Digital Pathology Test to Predict ...
Three abstracts will be presented during the annual San Antonio Breast Cancer Symposium (SABCS) taking place December 9-12, 2025, in San Antonio, TX.
- Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio ...
(Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology ... San Antonio Breast Cancer Symposium (SABCS), in San Antonio, TX ...